Appointments

Gelest names new CEO

"Dr. Barry Arkles has been appointed the Chief Executive Officer of Gelest Inc. effective immediately. "

  • By ICN Group | October 13, 2020

Gelest Inc. announced today that Dr. Barry Arkles, has been appointed the Chief Executive Officer of Gelest Inc. effective immediately. Dr. Arkles is also the Chairman of the Board of Gelest, the company he co-founded in 1991. On October 1, 2020 Gelest was acquired by Mitsubishi Chemical America, Inc., the U.S. subsidiary of Mitsubishi Chemical Corporation.
 
“Dr. Arkles’ comprehensive knowledge of the business and technology of Gelest provides excellent continuity as members of the talented leadership team join to support the continued growth of the
company in the key markets served: medical device, semiconductor, personal care, pharmaceutica and diagnostic science,” remarked Steve Yurich, President of MCA.
 
Dr. Arkles stated, “My primary objective will be to deploy the technological strengths of Gelest and its parent Mitsubishi Chemical in service to the customer base that depends on us and the communities that we serve. With the support of our reliable and talented employees, I anticipate a smooth transition into the Mitsubishi Chemical organization while sustaining the continued growth of Gelest.”
 
Dr. Arkles’ appointment follows the resignation of Ken Gayer as CEO of Gelest.

Click here to attend ICN's e-conference on 'Role of R&D in Making Chemical Industry Aatma Nirbhar'

More from Appointments

Start up

Chemical

Petrochemical

Digitization

Gas

Upcoming Conferences

Latest Stories

Report

Opinion

AI-powered drones for precision agriculture : The secret to scaling and sustenance
Opinion
AI-powered drones for precision agriculture : The secret to scaling and sustenance
Ankit Mehta Co-founder & CEO, ideaForge Technology
Need for intelligent chemical dosing pumps
Opinion
Need for intelligent chemical dosing pumps
Girish Laxmeshwar Associate Vice President, Business Development,Grundfos India.

Interviews

Most Viewed